X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Chinese Drug Packaging Reshaped By Plastics, Composites

Content Team by Content Team
8th September 2023
in News, Packaging & Logistic

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

As of the conclusion of 2018, Zenopa’s report reveals that the Chinese pharmaceutical packaging sector boasted an astonishing 106.8 billion yuan in value. What’s particularly striking is the noteworthy change in the materials employed for drug packaging, with plastic and composite materials emerging as pivotal players, constituting 43% and 24% of the industry’s total worth, respectively.

Traditionally reliant on conventional glass containers, the pharmaceutical realm has undergone a substantial transformation in its choice of packaging materials. In particular, plastic, embodied in the form of COP (Cyclic Olefin Polymer), has emerged as a compelling alternative. This shift is propelled by multiple factors, including its cost-effectiveness and exceptional durability.

COP containers have exhibited their resilience by providing enhanced safeguarding for medicinal products, ensuring their stability and efficacy. This transformation has not only captured the attention of pharmaceutical enterprises but has also set a higher standard for packaging excellence.

Within this evolving landscape, composite materials have also secured a notable portion of the pharmaceutical packaging sector, accounting for 24% of the market. These materials offer a unique amalgamation of traits, harnessing the strength of plastics while integrating other desirable attributes such as barrier protection and transparency.

The diversification in packaging materials not only offers pharmaceutical companies an array of choices but also stimulates innovation within the industry as manufacturers strive to meet the evolving requirements for sustainability and product integrity.

The implications of this shift in materials are twofold for the pharmaceutical industry. On the positive side, it promises cost efficiencies, improved preservation of medications, and increased design flexibility. However, it also raises concerns about sustainability and environmental impact.

Pharmaceutical companies and packaging manufacturers must carefully navigate this terrain, balancing the advantages of these contemporary materials with their responsibilities regarding plastic waste and environmental stewardship.

Undoubtedly, the continuous evolution of pharmaceutical packaging will play a pivotal role in shaping the future of drug delivery and patient care, ushering in a new era of possibilities and challenges alike.

Previous Post

Pharma Sector Fuels Demand For Asia Pacific Glass Packaging

Next Post

Drug Supply Chain Security Act Enforcement Delayed To 2024

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Drug Supply Chain Security Act Enforcement Delayed To 2024

Drug Supply Chain Security Act Enforcement Delayed To 2024

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In